Woodline Partners’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Woodline Partners’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-140,701	Closed	-$3.39M	–	828
2023 Q1	$3.39M	Buy	+140,701	New	+$1.77M	0.05%	346

Other funds holding PRVB

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Woodline Partners's PRVB Position: Q2 2023 in Review

Woodline Partners sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 140,701 shares — an estimated $3.39M sold.

Woodline Partners first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $3.39M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Woodline Partners reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Woodline Partners sold 140,701 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $3.39M.
Woodline Partners first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Woodline Partners's Provention Bio, Inc. Common Stock position peaked at $3.39M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.